Thus in conclusion, the in vitro results mostly support the bioinformatic predictions providing evidence that in ER- wtTP53 tumours, TP63 regulates expression of IFN-γ signalling genes and Δ133TP53 does so in ER+ mTP53 tumours. This evidence concerns the gene IFNG and neoplasm.